Europe Apheresis Market

The Europe apheresis market is projected to reach USD 1.07 billion by 2031 from USD 0.78 billion in 2026, at a CAGR of 6.6% from 2026 to 2031.

Apheresis is a process that utilizes specialized medical equipment to extract specific components from a donor's or patient's blood while simultaneously returning the remainder, either with or without additional extracorporeal treatment. This process uses devices and disposable materials that employ centrifugation and membrane separation/filtration technologies to isolate blood components precisely. The growth of this market is driven by an increase in the prevalence of chronic diseases and an upsurge in the number of trauma and injury cases.

To know about the assumptions considered for the study download the pdf brochure

The Europe apheresis market is highly consolidated and is dominated by key players. The major players operating in this market Terumo BCT, Inc. (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Cerus Corporation (US), Kaneka Corporation (Japan), SB-Kawasumi Laboratories, Inc (Japan), Nikkiso Co., Ltd (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co., Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Becton, Dickinson and Company (US), LMB Technologie GmbH (Germany), Bioelettronica S.r.l. (Italy), Infomed SA (Switzerland), Cytosorbents Corporation (US), Medicap clinic GmbH (Germany), Haier Biomedical (China), Beijing ZKSK Technology Co., Ltd. (China), Guangzhou Daji Medical Science and Technology Co., Ltd. (China), and PuriBlood Medical (Taiwan).

TERUMO BCT, INC. (JAPAN)

Terumo BCT Inc., a subsidiary of Terumo Corporation, specializes in developing healthcare solutions and products for the global market. In response to varying levels of access to safe blood and medical treatments worldwide, Terumo BCT focuses on therapeutic apheresis, blood components, and cellular technologies. The company's offerings include apheresis collections, manual and automated whole blood processing, pathogen reduction, therapeutic apheresis, and cell-processing technologies. Terumo BCT distinguishes itself with a comprehensive suite of cutting-edge products, exemplified by its Spectra Optia System. The company serves a diverse clientele, including hospitals, therapeutic apheresis centers, blood banks, biotech, and cell-processing centers. A significant portion of the company's resources is dedicated to research and development, resulting in an expanded portfolio of innovative products. Moreover, Terumo BCT has a robust presence across various regions, with key markets in Asia, China, Japan, America, and EMEA. Through these strategic initiatives, Terumo aims to solidify its position as a leading player in the apheresis industry, positioning itself for sustained growth and success.

FRESENIUS SE & CO. KGAA (GERMANY)

Fresenius SE & CO. KGaA, a leading global healthcare conglomerate, specializes in dialysis, hospital management, and outpatient medical services. The company is committed to project management and to delivering comprehensive healthcare solutions to institutions worldwide. Its strategic focus includes penetrating emerging markets to bolster competitiveness. Apheresis products are marketed through its two key business divisions, Fresenius Kabi and Fresenius Medical Care, serving both donor and therapeutic procedures. To ensure sustainable future growth and secure a competitive advantage in the dynamic healthcare sector, the company emphasizes research and development. Targeting various end users, including hospitals, healthcare facilities, professionals, and dialysis service providers, Fresenius boasts a substantial presence across North America, Europe, the Asia Pacific, Latin America, and Africa, supported by robust distribution networks spanning all continents.

HAEMONETICS CORPORATION (GERMANY)

Haemonetics Corporation is a pivotal player in the apheresis market, renowned for its innovative solutions and comprehensive suite of apheresis equipment. As a leading global healthcare corporation, Haemonetics is dedicated to advancing patient care while optimizing healthcare cost efficiencies. Haemonetics provides advanced apheresis devices for both blood donation centers and hospitals, supporting applications such as plasmapheresis, plateletpheresis, and leukapheresis. Haemonetics' robust growth strategies encompass both organic and inorganic approaches, enabling the company to expand its market presence and capture new opportunities. This strategic approach ensures sustained relevance and competitiveness in the dynamic apheresis landscape. Moreover, the company has a substantial operational footprint spanning major regions, including the US, Europe, Japan, and various parts of Asia. It has effectively penetrated key markets and serves a diverse clientele. Its products are marketed in approximately 90 countries worldwide, showcasing its global reach and market leadership.

Market Ranking

The Europe apheresis market is consolidated and dominated by major players, including Terumo BCT, Inc. (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), and Asahi Kasei Medical Co., Ltd. (Japan), which together account for the largest share of the market. The leading players have strong global networks and established distribution in regions such as North America and Europe. These companies leverage partnerships, advanced R&D, and brand strength to maintain their lead. Meanwhile, smaller players compete by offering low-cost products and innovative technologies, resulting in a market landscape that combines dominant companies with agile, competitive regional providers.

Related Reports:

Europe Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure [Donor, Therapeutic], Application [Plasmapheresis, Plateletpheresis, Leukapheresis], Technology [Centrifugation], End User-Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com